Leveraging AI to transform
diabetic patient's lives.
Because each patient is different,
a personalized approach is needed.
Custom AI-based Model
Patented process
Patient specific model for BGL prediction
Based on Machine Learning and Pharmacokinetics
Requiring less than 10 days of data for training
Decision Support
Telemedicine & retrospective analysis
Personalized therapeutic education
-
Better insights on BGL fluctuations
-
Real-time prediction to anticipate risks
Open Loop
Decision-support for patients
Connected logbook
-
Track lifestyle data (activity, meal)
-
Personalized advices
Closed Loop
Higher time-in-range
Allow for more personalization and better regulation of the system
-
Handle complex living phases with rapid glucose changes
Want to learn more?
Check out our Scientific Papers
The team behind the scene.
Stéphane Bidet
CEO & Co-founder
Stéphane graduated with a master’s degree from UTC (Technical University of Compiègne). He then worked 1 year as a research engineer at the University of Queensland (Australia), 2.5 years as software engineer in a Californian mobile/web software house (Hands-on Mobile), and then he worked as sales manager and business unit director in a leading European consulting firm.Fields of expertise: mobile app development, sales and business development.
Pr. Eric Renard
Diabetes specialist
Pr. Eric Renard is world renowned endocrinologist, Head of the Department of Endocrinology, Diabetes and Nutrition, Lapeyronie University Hospital, Montpellier, France. His main field of clinical research is focused on intensive insulin therapy aiming at physiological insulin delivery. He devoted a large part of his work on developing insulin pump therapy and development of tools for continuous blood glucose monitoring. In years 2000-2007, he investigated in diabetic humans the first model of fully implantable artificial endocrine pancreas. His recent research includes participation in European FP7 Projects ‘DIAdvisor’, ‘Bringing Artificial Pancreas at home’, BIOSID and in JDRF-sponsored Artificial Pancreas Project. Eric Renard authored more than 120 papers in peer-reviewed journals.
Nicolas Caleca
CSO & Co-founder
Nicolas graduated with a master’s degree from Ecole Polytechnique and ENSAE. He then worked at AREVA for 6 years as a design and development engineer, and then as a project manager. In 2013, he was hired as Technical Director in a leading European consulting firm. During more than 2 years, he managed engineering and industrial projects, from pre-sales to after-sales support, for all subsidiaries in Europe. Fields of expertise: simulation and mathematics, project management.
Dr. Marc Breton
Algorithm specialist
Dr. Marc Breton is an Associate Professor at the University of Virginia School of Medicine and the Associate Director for Research at the UVA Center for Diabetes Technology. He has been a member of UVA faculty since 2006, published over 80 articles in peer reviewed journal and holds over 30 patents, copyrights, and disclosures. His research is centered on bringing engineering techniques such as mathematical modeling, simulation, signal processing and automatic control into the field of medicine and clinical practice. He has been successful at applying these techniques to the field of diabetes technology, in particular the assessment and control of sugar levels in type 1 diabetes mellitus.
Hillo
hillo obtained CE mark approval for its AI
Challenges
hillo among the top 100 start-ups in which to invest
Le Monde
hillo part of the French e-health delegation at CES 2019
BFM TV
An innovative app for diabetic patients
